Cargando…
Bcl-2 antagonists and cancer: from the clinic, back to the bench
Autor principal: | Esposti, M Degli |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032303/ https://www.ncbi.nlm.nih.gov/pubmed/21364644 http://dx.doi.org/10.1038/cddis.2010.15 |
Ejemplares similares
-
Human genetics moves from clinic to bench - and back
por: Ogorelkova, Miroslava, et al.
Publicado: (2005) -
T-cell co-stimulatory blockade in kidney transplantation: back to the bench
por: Riella, Leonardo V, et al.
Publicado: (2011) -
Highlights of Keystone symposium ‘Fibrosis: from bench to bedside’
por: de Haan, Judith Jeanette, et al.
Publicado: (2014) -
The new ParaDIgm: IgM from bench to clinic: November 15–16, 2011, Frankfurt, Germany
por: Hanala, Sherif
Publicado: (2012) -
Hypoxia in obesity - from bench to bedside
por: Ye, Jianping
Publicado: (2012)